Capillus announces its support of breast cancer research by pledging to donate 3% of online sales of Capillus laser therapy caps to the National Breast Cancer Foundation during October, National Breast Cancer Awareness Month.
Capillus announces its support of breast cancer research by pledging to donate 3% of online sales of Capillus laser therapy caps to the National Breast Cancer Foundation during October, National Breast Cancer Awareness Month. Each Capillus laser purchase includes a bonus pink Capillus sports cap.
“The National Breast Cancer Foundation is such an amazing organization who has helped millions of women and men,” said Frances Piña-Brea, Capillus Chief Marketing Officer. “We are excited to provide an opportunity for our customers to contribute to the fight in finding a cure and bring awareness to a disease which affects entire families.”
Breast cancer is one of the leading health crises for women in the United States. One in 8 women will be diagnosed with breast cancer in her lifetime. Capillus is committed to joining help women and men fighting breast cancer.
Capillus currently offers three FDA-Cleared laser caps for direct sale via https://www.capillus.com. Our Capillus laser caps models (Capillus82™, Capillus202™, CapillusPro™) start at 82 laser diodes with great coverage and range up to our premier 272 laser diodes caps. Capillus Low-Level Laser Therapy (LLLT) caps are non-surgical options that have been proven to promote hair regrowth in men and women who battle hereditary hair loss.* Each Capillus laser therapy cap provides controlled, precise, and consistent delivery of laser energy during its 6-minute session with a flexible comfort fit.
Three percent of online sales of each Capillus laser purchase now till the end of October will be donated to assist the National Breast Cancer Foundation to provide early screening tests, breast cancer education, and support services, to women all over the country. Capillus encourages readers to visit Capillus.com to learn more about October Breast Cancer Awareness Month.
*Most laser therapy devices are cleared by the USA FDA for adults suffering from androgenetic alopecia. None have been cleared specifically for chemotherapy-induced hair loss. The USFDA has not evaluated claims for the use of LLLT under the conditions stated here.
